To further study the relationship between high CD44 levels in gliomas and tumor immunity function, we performed CIBERSORT, MCPcounter, and TIMER analyses to determine whether the typical immune cells responsible for the immune responses against tumors or participating in the inflammatory activity are related to high CD44 expression. This evidence concerns the gene CD44 and central nervous system cancer.